COMPANY

Normunity

HQ: Boston, MA source · normunity.com ↗ · New England

Keywords: oncology cancer antibody solid tumors

Location: Boston, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series B · $75M · announced Jan 13, 2025 Company release ↗
Source quote
- Jan 13, 2025 · Company release ↗
  “Normunity closes $75 million Series B financing to advance lead drug program into the clinic and broaden pipeline of novel anti-cancer therapies targeting untapped drug mechanisms Financing co-led by Samsara Biocapital and Enavate Sciences, with participation from Pfizer Ventures and Regeneron”

Raises announced in these releases: $75M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Jan 13, 2025 Raise Private equity round — Series B: $75M (total, as published), announced Jan 13, 2025. Source: company's own press page. source ↗
Jan 13, 2025 Raise Series B · $75M source ↗

Raised: $75.0M. Last 2 years.

Jan 13, 2025 Private equity round — Series B: $75M (total, as published), announced Jan 13, 2025. Source: company's own press page. source ↗